In recent years, GDF15 has consistently been described as associated with sarcopenia and cachexia (Kamper et al. 2024), a clinical feature of severity which may also be observed in patients with AN (Tarchi, Cassioli, et al. 2024). Here, GDF15 is linked to Cachexia.